LEO, MARENZA Statistiche
LEO, MARENZA
DIREZIONE AREA DI MEDICINA
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial
2021-01-01 Lanzolla, Giulia; Sabini, Elena; Leo, Marenza; Menconi, Francesca; Rocchi, Roberto; Sframeli, Angela; Piaggi, Paolo; Nardi, Marco; Marcocci, Claudio; Marinò, Michele
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study
2020-01-01 Perros, P.; Zarkovic, M. P.; Panagiotou, G. C.; Azzolini, C.; Ayvaz, G.; Baldeschi, L.; Bartalena, L.; Boschi, A. M.; Nardi, M.; Brix, T. H.; Covelli, D.; Daumerie, C.; Eckstein, A. K.; Fichter, N.; Ciric, S.; Hegedus, L.; Kahaly, G. J.; Konuk, O.; Lareida, J. J.; Okosieme, O. E.; Leo, M.; Mathiopoulou, L.; Clarke, L.; Menconi, F.; Morris, D. S.; Orgiazzi, J.; Pitz, S.; Salvi, M.; Muller, I.; Knezevic, M.; Wiersinga, W. M.; Curro, N.; Dayan, C. M.; Marcocci, C.; Marino, M.; Moller, L.; Pearce, S. H.; Toruner, F.; Bernard, M.; Perros, P.; Lareida, J. J.
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy
2020-01-01 Nicoli, F.; Lanzolla, G.; Mantuano, M.; Ionni, I.; Mazzi, B.; Leo, M.; Sframeli, A.; Posarelli, C.; Maglionico, M. N.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M.
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis
2020-01-01 Rotondo Dottore, Giovanna; Leo, Marenza; Ricciardi, Roberta; Maestri, Michelangelo; Bucci, Ilaria; Lucchi, Marco; Melfi, Franca; Guida, Melania; De Rosa, Anna; Petrucci, Loredana; Ionni, Ilaria; Lanzolla, Giulia; Nicolì, Francesca; Mantuano, Michele; Ricci, Debora; Latrofa, Francesco; Mariotti, Stefano; Marcocci, Claudio; Marinò, Michele
Combined mycophenolate + prednisolone therapy is more effective than prednisolone in active and moderate-to-severe Graves’ Orbitopathy – A randomized, observer blind, multicenter trial
2018-01-01 Kahaly, Gj; Riedl, M; König, J; Pitz, S; Kampmann, E; Kolbe, E; Ponto, Ka; Diana, T; Eckstein, A; Müller, L; Führer, D; Salvi, M; Campi, I; Covelli, D; Curro, N; Leo, M; Marinò, M; Menconi, F; Marcocci, C; Bartalena, L; Perros, P; Wiersinga, Wm
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study
2018-01-01 Sabini, Elena; Mazzi, Barbara; Profilo, Maria Antonietta; Mautone, Teresa; Casini, Giamberto; Rocchi, Roberto; Ionni, Ilaria; Menconi, Francesca; Leo, Marenza; Nardi, Marco; Vitti, Paolo; Marcocci, Claudio; Marinò, Michele
Mechanistic Pathways of Selenium in the Treatment of Graves' Disease and Graves' Orbitopathy
2018-01-01 Marinò, Michele; Rotondo Dottore, Giovanna; Leo, Marenza; Marcocci, Claudio
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study
2018-01-01 Lanzolla, Giulia; Sabini, E.; Profilo, M. A.; Mazzi, B.; Sframeli, A.; Rocchi, R.; Menconi, F.; Leo, M.; Nardi, M.; Vitti, P.; Marcocci, C.; Marinò, M.
Selenium in Graves Hyperthyroidism and Orbitopathy
2018-01-01 Marinò, Michele; Menconi, Francesca; Rotondo Dottore, Giovanna; Leo, Marenza; Marcocci, Claudio
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question
2017-01-01 Sabini, Elena; Leo, Marenza; Mazzi, Barbara; Rocchi, Roberto; Latrofa, Francesco; Nardi, Marco; Vitti, Paolo; Marcocci, Claudio; Marinò, Michele
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial
2017-01-01 Leo, Marenza; Bartalena, L; Rotondo Dottore, G; Piantanida, E; Premoli, P; Ionni, Ilaria; Di Cera, M; Masiello, E; Sassi, L; Tanda, M. L; Latrofa, Francesco; Vitti, Paolo; Marcocci, Claudio; Marino', Michele
Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves’ orbitopathy
2017-01-01 Dottore, Giovanna Rotondo; Chiarini, Riccardo; de Gregorio, Maria; Leo, Marenza; Casini, Giamberto; Cestari, Luca; SELLARI FRANCESCHINI, Stefano; Nardi, Marco; Vitti, Paolo; Marcocci, Claudio; Marino', Michele
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients
2017-01-01 Leo, M.; Sabini, E.; Ionni, I.; Sframeli, A.; Mazzi, B.; Menconi, F.; Molinaro, E.; Bianchi, F.; Brozzi, F.; Santini, Pietro; Elisei, R.; Nardi, M.; Vitti, P.; Marcocci, C.; CACERES GARCIA DE MARINA, MARIA DE LA PALOMA
Use of low-dose radioiodine ablation for Gravesâ orbitopathy: results of a pilot, perspective study in a small series of patients
2017-01-01 Leo, M.; Sabini, E.; Ionni, I.; Sframeli, A.; Mazzi, B.; Menconi, F.; Molinaro, E.; Bianchi, F.; Brozzi, F.; Santini, P.; Elisei, R.; Nardi, M.; Vitti, P.; Marcocci, C.; Marinò, M.
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy
2016-01-01 Rotondo Dottore, Giovanna; Leo, Marenza; Casini, Giamberto; Latrofa, Francesco; Cestari, Luca; SELLARI FRANCESCHINI, Stefano; Nardi, Marco; Vitti, Paolo; Marcocci, Claudio; Marino', Michele
Dissecting the genetic susceptibility to graves' disease in a cohort of patients of Italian origin
2016-01-01 Lombardi, Angela; Menconi, Francesca; Greenberg, David; Concepcion, Erlinda; Leo, Marenza; Rocchi, Roberto; Marino', Michele; Keddache, Mehdi; Tomer, Yaron
Natural history of graves’ orbitopathy after treatment
2016-01-01 Menconi, Francesca; Leo, Marenza; Sabini, Elena; Mautone, Teresa; Nardi, Marco; Sainato, Aldo; SELLARI FRANCESCHINI, Stefano; Vitti, Paolo; Marcocci, Claudio; Marino', Michele
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy
2016-01-01 Sabini, Elena; Sisti, Eleonora; Coco, B; Leo, Marenza; Ionni, Ilaria; Menconi, Francesca; Profilo, M. A; Mazzi, B; Rocchi, Roberto; Latrofa, Francesco; Vitti, Paolo; Brunetto, MAURIZIA ROSSANA; Marcocci, Claudio; Marino', Michele
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY
2016-01-01 Leo, Marenza; Mautone, Teresa; Ionni, Ilaria; Profilo, MARIA ANTONIETTA; Sabini, Elena; Menconi, Francesca; Mazzi, Barbara; Rocchi, Roberto; Latrofa, Francesco; Nardi, Marco; Vitti, Paolo; Marcocci, Claudio; Marino', Michele
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy
2015-01-01 Sisti, Eleonora; Coco, Barbara; Menconi, Francesca; Leo, Marenza; Rocchi, Roberto; Latrofa, Francesco; Profilo, MARIA ANTONIETTA; Mazzi, Barbara; Vitti, Paolo; Marcocci, Claudio; Brunetto, MAURIZIA ROSSANA; Marino', Michele
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial | 1-gen-2021 | Lanzolla, Giulia; Sabini, Elena; Leo, Marenza; Menconi, Francesca; Rocchi, Roberto; Sframeli, Angela; Piaggi, Paolo; Nardi, Marco; Marcocci, Claudio; Marinò, Michele | |
| Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study | 1-gen-2020 | Perros, P.; Zarkovic, M. P.; Panagiotou, G. C.; Azzolini, C.; Ayvaz, G.; Baldeschi, L.; Bartalena, L.; Boschi, A. M.; Nardi, M.; Brix, T. H.; Covelli, D.; Daumerie, C.; Eckstein, A. K.; Fichter, N.; Ciric, S.; Hegedus, L.; Kahaly, G. J.; Konuk, O.; Lareida, J. J.; Okosieme, O. E.; Leo, M.; Mathiopoulou, L.; Clarke, L.; Menconi, F.; Morris, D. S.; Orgiazzi, J.; Pitz, S.; Salvi, M.; Muller, I.; Knezevic, M.; Wiersinga, W. M.; Curro, N.; Dayan, C. M.; Marcocci, C.; Marino, M.; Moller, L.; Pearce, S. H.; Toruner, F.; Bernard, M.; Perros, P.; Lareida, J. J. | |
| Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy | 1-gen-2020 | Nicoli, F.; Lanzolla, G.; Mantuano, M.; Ionni, I.; Mazzi, B.; Leo, M.; Sframeli, A.; Posarelli, C.; Maglionico, M. N.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M. | |
| Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis | 1-gen-2020 | Rotondo Dottore, Giovanna; Leo, Marenza; Ricciardi, Roberta; Maestri, Michelangelo; Bucci, Ilaria; Lucchi, Marco; Melfi, Franca; Guida, Melania; De Rosa, Anna; Petrucci, Loredana; Ionni, Ilaria; Lanzolla, Giulia; Nicolì, Francesca; Mantuano, Michele; Ricci, Debora; Latrofa, Francesco; Mariotti, Stefano; Marcocci, Claudio; Marinò, Michele | |
| Combined mycophenolate + prednisolone therapy is more effective than prednisolone in active and moderate-to-severe Graves’ Orbitopathy – A randomized, observer blind, multicenter trial | 1-gen-2018 | Kahaly, Gj; Riedl, M; König, J; Pitz, S; Kampmann, E; Kolbe, E; Ponto, Ka; Diana, T; Eckstein, A; Müller, L; Führer, D; Salvi, M; Campi, I; Covelli, D; Curro, N; Leo, M; Marinò, M; Menconi, F; Marcocci, C; Bartalena, L; Perros, P; Wiersinga, Wm | |
| High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study | 1-gen-2018 | Sabini, Elena; Mazzi, Barbara; Profilo, Maria Antonietta; Mautone, Teresa; Casini, Giamberto; Rocchi, Roberto; Ionni, Ilaria; Menconi, Francesca; Leo, Marenza; Nardi, Marco; Vitti, Paolo; Marcocci, Claudio; Marinò, Michele | |
| Mechanistic Pathways of Selenium in the Treatment of Graves' Disease and Graves' Orbitopathy | 1-gen-2018 | Marinò, Michele; Rotondo Dottore, Giovanna; Leo, Marenza; Marcocci, Claudio | |
| Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study | 1-gen-2018 | Lanzolla, Giulia; Sabini, E.; Profilo, M. A.; Mazzi, B.; Sframeli, A.; Rocchi, R.; Menconi, F.; Leo, M.; Nardi, M.; Vitti, P.; Marcocci, C.; Marinò, M. | |
| Selenium in Graves Hyperthyroidism and Orbitopathy | 1-gen-2018 | Marinò, Michele; Menconi, Francesca; Rotondo Dottore, Giovanna; Leo, Marenza; Marcocci, Claudio | |
| Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question | 1-gen-2017 | Sabini, Elena; Leo, Marenza; Mazzi, Barbara; Rocchi, Roberto; Latrofa, Francesco; Nardi, Marco; Vitti, Paolo; Marcocci, Claudio; Marinò, Michele | |
| Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial | 1-gen-2017 | Leo, Marenza; Bartalena, L; Rotondo Dottore, G; Piantanida, E; Premoli, P; Ionni, Ilaria; Di Cera, M; Masiello, E; Sassi, L; Tanda, M. L; Latrofa, Francesco; Vitti, Paolo; Marcocci, Claudio; Marino', Michele | |
| Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves’ orbitopathy | 1-gen-2017 | Dottore, Giovanna Rotondo; Chiarini, Riccardo; de Gregorio, Maria; Leo, Marenza; Casini, Giamberto; Cestari, Luca; SELLARI FRANCESCHINI, Stefano; Nardi, Marco; Vitti, Paolo; Marcocci, Claudio; Marino', Michele | |
| Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients | 1-gen-2017 | Leo, M.; Sabini, E.; Ionni, I.; Sframeli, A.; Mazzi, B.; Menconi, F.; Molinaro, E.; Bianchi, F.; Brozzi, F.; Santini, Pietro; Elisei, R.; Nardi, M.; Vitti, P.; Marcocci, C.; CACERES GARCIA DE MARINA, MARIA DE LA PALOMA | |
| Use of low-dose radioiodine ablation for Gravesâ orbitopathy: results of a pilot, perspective study in a small series of patients | 1-gen-2017 | Leo, M.; Sabini, E.; Ionni, I.; Sframeli, A.; Mazzi, B.; Menconi, F.; Molinaro, E.; Bianchi, F.; Brozzi, F.; Santini, P.; Elisei, R.; Nardi, M.; Vitti, P.; Marcocci, C.; Marinò, M. | |
| Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy | 1-gen-2016 | Rotondo Dottore, Giovanna; Leo, Marenza; Casini, Giamberto; Latrofa, Francesco; Cestari, Luca; SELLARI FRANCESCHINI, Stefano; Nardi, Marco; Vitti, Paolo; Marcocci, Claudio; Marino', Michele | |
| Dissecting the genetic susceptibility to graves' disease in a cohort of patients of Italian origin | 1-gen-2016 | Lombardi, Angela; Menconi, Francesca; Greenberg, David; Concepcion, Erlinda; Leo, Marenza; Rocchi, Roberto; Marino', Michele; Keddache, Mehdi; Tomer, Yaron | |
| Natural history of graves’ orbitopathy after treatment | 1-gen-2016 | Menconi, Francesca; Leo, Marenza; Sabini, Elena; Mautone, Teresa; Nardi, Marco; Sainato, Aldo; SELLARI FRANCESCHINI, Stefano; Vitti, Paolo; Marcocci, Claudio; Marino', Michele | |
| Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy | 1-gen-2016 | Sabini, Elena; Sisti, Eleonora; Coco, B; Leo, Marenza; Ionni, Ilaria; Menconi, Francesca; Profilo, M. A; Mazzi, B; Rocchi, Roberto; Latrofa, Francesco; Vitti, Paolo; Brunetto, MAURIZIA ROSSANA; Marcocci, Claudio; Marino', Michele | |
| VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY | 1-gen-2016 | Leo, Marenza; Mautone, Teresa; Ionni, Ilaria; Profilo, MARIA ANTONIETTA; Sabini, Elena; Menconi, Francesca; Mazzi, Barbara; Rocchi, Roberto; Latrofa, Francesco; Nardi, Marco; Vitti, Paolo; Marcocci, Claudio; Marino', Michele | |
| Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy | 1-gen-2015 | Sisti, Eleonora; Coco, Barbara; Menconi, Francesca; Leo, Marenza; Rocchi, Roberto; Latrofa, Francesco; Profilo, MARIA ANTONIETTA; Mazzi, Barbara; Vitti, Paolo; Marcocci, Claudio; Brunetto, MAURIZIA ROSSANA; Marino', Michele |